ticker large_stringclasses 498
values | fy int64 2.02k 2.03k | topic large_stringclasses 13
values | rank int64 1 3 | chunk_id large_stringlengths 18 23 | pid int64 0 126k | sector large_stringclasses 11
values | rrf float64 0.02 0.03 | off_topic bool 2
classes | polarity_evidence large_stringlengths 0 731 | polarity int64 -2 2 | magnitude_evidence large_stringlengths 0 468 | magnitude int64 0 3 | realization_evidence large_stringlengths 0 515 | realization int64 0 2 | uncertainty_evidence large_stringlengths 0 588 | uncertainty int64 0 3 | specificity_evidence large_stringlengths 0 554 | specificity int64 0 2 | model large_stringclasses 1
value | usd float64 0 0 | item large_stringclasses 2
values | filing_date large_stringdate 2019-02-21 00:00:00 2026-10-09 00:00:00 | report_date large_stringdate 2019-01-27 00:00:00 2026-09-03 00:00:00 | accession large_stringlengths 20 20 | names_topic bool 2
classes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | 2,019 | China | 1 | A_10-K_2019_1A_0002 | 0 | Health Care | 0.032522 | false | could adversely affect our results of operations; tariffs enacted and proposed by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; could have a material adverse effect | -1 | could have a material adverse effect on our business, results of operations and financial condition | 1 | tariffs enacted and proposed by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; Tariffs recently announced and implemented | 1 | the scope and duration of which, if implemented, remains uncertain | 3 | tariffs enacted and proposed by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000143 | 1A | 2019-12-19 | 2019-10-31 | 0001090872-19-000022 | true |
A | 2,019 | China | 2 | A_10-K_2019_1A_0006 | 1 | Health Care | 0.031545 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.00016 | 1A | 2019-12-19 | 2019-10-31 | 0001090872-19-000022 | false | |||||
A | 2,019 | China | 3 | A_10-K_2019_1A_0005 | 2 | Health Care | 0.031514 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000139 | 1A | 2019-12-19 | 2019-10-31 | 0001090872-19-000022 | false | |||||
A | 2,020 | China | 1 | A_10-K_2020_1A_0004 | 3 | Health Care | 0.032787 | false | Future tariffs and tariffs already implemented could have negative impact on our business | -1 | could have a material adverse effect on our business, results of operations and financial condition | 1 | tariffs already implemented | 1 | the scope and duration of which, if implemented, remains uncertain | 3 | tariffs enacted and proposed by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000122 | 1A | 2020-12-18 | 2020-10-31 | 0001090872-20-000020 | true |
A | 2,020 | China | 2 | A_10-K_2020_1A_0007 | 4 | Health Care | 0.032002 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000152 | 1A | 2020-12-18 | 2020-10-31 | 0001090872-20-000020 | false | |||||
A | 2,020 | China | 3 | A_10-K_2020_1A_0009 | 5 | Health Care | 0.031754 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000112 | 1A | 2020-12-18 | 2020-10-31 | 0001090872-20-000020 | false | |||||
A | 2,021 | China | 1 | A_10-K_2021_1A_0004 | 6 | Health Care | 0.032787 | false | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; Future tariffs and tariffs already implemented could have negative impact on our business | -1 | could have a material adverse effect on our business, results of operations and financial condition | 1 | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; tariffs already implemented | 2 | the scope and duration of which, if implemented, remains uncertain | 3 | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000146 | 1A | 2021-12-17 | 2021-10-31 | 0001090872-21-000027 | true |
A | 2,021 | China | 2 | A_10-K_2021_1A_0007 | 7 | Health Care | 0.031514 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000092 | 1A | 2021-12-17 | 2021-10-31 | 0001090872-21-000027 | false | |||||
A | 2,021 | China | 3 | A_10-K_2021_1A_0009 | 8 | Health Care | 0.03101 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000138 | 1A | 2021-12-17 | 2021-10-31 | 0001090872-21-000027 | false | |||||
A | 2,022 | China | 1 | A_10-K_2022_1A_0004 | 9 | Health Care | 0.032787 | false | changes in diplomatic and trade relationships; tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; political and trade uncertainties in the greater China region | -1 | could have a material adverse effect on our business, results of operations and financial condition | 2 | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; tariffs already implemented | 1 | the scope and duration of which, if implemented, remains uncertain | 3 | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000152 | 1A | 2022-12-21 | 2022-10-31 | 0001090872-22-000026 | true |
A | 2,022 | China | 2 | A_10-K_2022_1A_0007 | 10 | Health Care | 0.032002 | false | China's Personal Information Protection Law and Data Security Law, apply to our activities involving the processing of personal data | -1 | 0 | China's Personal Information Protection Law and Data Security Law, apply to our activities | 1 | Each of these privacy, security and data protection laws and regulations could impose significant limitations and increase our cost | 2 | China's Personal Information Protection Law and Data Security Law | 2 | claude-haiku-5-5 | 0.000246 | 1A | 2022-12-21 | 2022-10-31 | 0001090872-22-000026 | true | |
A | 2,022 | China | 3 | A_10-K_2022_1A_0009 | 11 | Health Care | 0.03125 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000157 | 1A | 2022-12-21 | 2022-10-31 | 0001090872-22-000026 | false | |||||
A | 2,023 | China | 1 | A_10-K_2023_1A_0002 | 12 | Health Care | 0.032787 | false | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; Future tariffs and tariffs already implemented could have negative impact on our business | -1 | could have a material adverse effect on our business, results of operations and financial condition | 1 | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | the scope and duration of which, if implemented, remains uncertain | 2 | the tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000143 | 1A | 2023-12-20 | 2023-10-31 | 0001090872-23-000020 | true |
A | 2,023 | China | 2 | A_10-K_2023_1A_0007 | 13 | Health Care | 0.031514 | false | China's Personal Information Protection Law and Data Security Law, apply to our activities involving the processing of personal data | -1 | 0 | China's Personal Information Protection Law and Data Security Law, apply to our activities involving the processing of personal data | 1 | Each of these privacy, security and data protection laws and regulations could impose significant limitations and increase our cost | 2 | China's Personal Information Protection Law and Data Security Law | 2 | claude-haiku-5-5 | 0.000255 | 1A | 2023-12-20 | 2023-10-31 | 0001090872-23-000020 | true | |
A | 2,023 | China | 3 | A_10-K_2023_1A_0009 | 14 | Health Care | 0.031498 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000137 | 1A | 2023-12-20 | 2023-10-31 | 0001090872-23-000020 | false | |||||
A | 2,024 | China | 1 | A_10-K_2024_1A_0002 | 15 | Health Care | 0.032787 | false | Future tariffs and tariffs already implemented could have negative impact on our business; tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | -1 | could have a material adverse effect on our business, results of operations and financial condition | 1 | tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; tariffs already implemented | 2 | the scope and duration of which, if implemented, remains uncertain | 3 | the tariffs enacted by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000142 | 1A | 2024-12-20 | 2024-10-31 | 0001090872-24-000049 | true |
A | 2,024 | China | 2 | A_10-K_2024_1A_0017 | 16 | Health Care | 0.031746 | false | China's Data Security Law | -1 | 0 | with similar applicable requirements under the EU's NIS2 Directive and China's Data Security Law | 2 | 0 | China's Data Security Law | 2 | claude-haiku-5-5 | 0.000073 | 1A | 2024-12-20 | 2024-10-31 | 0001090872-24-000049 | true | ||
A | 2,024 | China | 3 | A_10-K_2024_1A_0007 | 17 | Health Care | 0.031514 | false | Global privacy laws, including ... China's Personal Information Protection Law and Data Security Law, apply to our activities involving the processing of personal data ... could harm our results of operations | -1 | 0 | China's Personal Information Protection Law and Data Security Law, apply to our activities | 1 | Each of these privacy, security and data protection laws and regulations could impose significant limitations and increase our cost | 2 | China's Personal Information Protection Law and Data Security Law | 2 | claude-haiku-5-5 | 0.000243 | 1A | 2024-12-20 | 2024-10-31 | 0001090872-24-000049 | true | |
A | 2,025 | China | 1 | A_10-K_2025_1A_0001 | 18 | Health Care | 0.032787 | false | tariffs and trade policies by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods; trade war and retaliatory measures could have a material adverse effect | -1 | could have a material adverse effect on our business, results of operations and financial condition | 1 | tariffs already implemented; tariffs and trade policies by the U.S. government on various imports from China | 1 | additional tariffs, the scope and duration of which, if implemented, remain uncertain | 3 | tariffs and trade policies by the U.S. government on various imports from China and by the Chinese government on certain U.S. goods | 2 | claude-haiku-5-5 | 0.000145 | 1A | 2025-12-22 | 2025-10-31 | 0001090872-25-000087 | true |
A | 2,025 | China | 2 | A_10-K_2025_1A_0003 | 19 | Health Care | 0.031746 | false | tariffs, sanctions, and export controls, may restrict our ability to ship products globally; Failure to comply with these regulations could result in penalties, loss of export privileges | -1 | could result in significant costs and require modifications in the way we and our customers conduct business | 1 | The rapid increase in new government regulations, including tariffs and proposed tariffs | 1 | could result in significant costs; could affect our revenue; may restrict our ability to ship products globally | 2 | tariffs, sanctions, and export controls; loss of export privileges | 1 | claude-haiku-5-5 | 0.00014 | 1A | 2025-12-22 | 2025-10-31 | 0001090872-25-000087 | false |
A | 2,025 | China | 3 | A_10-K_2025_1A_0007 | 20 | Health Care | 0.031281 | false | could impose significant limitations and increase our cost of providing our products and services where we process personal data and could harm our results of operations | -1 | 0 | China's Personal Information Protection Law and Data Security Law, the California Consumer Privacy Act and Brazil's Lei Geral de Protecao de Dados, apply to our activities | 1 | could impose significant limitations and increase our cost of providing our products and services where we process personal data and could harm our results of operations and expose us to significant fines | 2 | China's Personal Information Protection Law and Data Security Law | 2 | claude-haiku-5-5 | 0.000253 | 1A | 2025-12-22 | 2025-10-31 | 0001090872-25-000087 | true | |
AAPL | 2,019 | China | 1 | AAPL_10-K_2019_1A_0012 | 21 | Information Technology | 0.032787 | false | trade tensions have led to a series of tariffs imposed by the U.S. on imports from China. Tariffs increase the cost of the Company's products | -1 | These increased costs adversely impact the gross margin that the Company earns on its products. | 2 | trade tensions have led to a series of tariffs imposed by the U.S. on imports from China | 2 | Political uncertainty surrounding international trade disputes and measures could also have a negative effect on consumer confidence and spending | 2 | a series of tariffs imposed by the U.S. on imports from China | 2 | claude-haiku-5-5 | 0.000137 | 1A | 2019-10-31 | 2019-09-28 | 0000320193-19-000119 | true |
AAPL | 2,019 | China | 2 | AAPL_10-K_2019_7_0006 | 22 | Information Technology | 0.031498 | false | Greater China net sales decreased during 2019 compared to 2018 due primarily to lower iPhone net sales | -1 | Greater China net sales decreased during 2019 compared to 2018 due primarily to lower iPhone net sales, partially offset by higher Wearables, Home and Accessories and Services net sales | 2 | Greater China net sales decreased during 2019 compared to 2018 | 2 | 0 | Greater China net sales decreased during 2019 compared to 2018 due primarily to lower iPhone net sales | 2 | claude-haiku-5-5 | 0.0001 | 7 | 2019-10-31 | 2019-09-28 | 0000320193-19-000119 | true | |
AAPL | 2,019 | China | 3 | AAPL_10-K_2019_1A_0004 | 23 | Information Technology | 0.031281 | false | international trade disputes | -1 | 0 | 0 | could be materially adversely affected | 2 | 0 | claude-haiku-5-5 | 0.000095 | 1A | 2019-10-31 | 2019-09-28 | 0000320193-19-000119 | false | |||
AAPL | 2,020 | China | 1 | AAPL_10-K_2020_1A_0013 | 24 | Information Technology | 0.032787 | false | tensions between the U.S. and China have led to a series of tariffs being imposed by the U.S. on imports from China mainland, as well as other business restrictions. Tariffs may increase the cost of the Company's products | -1 | These increased costs adversely impact the gross margin that the Company earns on its products | 1 | tensions between the U.S. and China have led to a series of tariffs being imposed by the U.S. on imports from China mainland | 2 | could make the Company's products less competitive and reduce consumer demand | 2 | a series of tariffs being imposed by the U.S. on imports from China mainland | 2 | claude-haiku-5-5 | 0.000157 | 1A | 2020-10-30 | 2020-09-26 | 0000320193-20-000096 | true |
AAPL | 2,020 | China | 2 | AAPL_10-K_2020_1A_0016 | 25 | Information Technology | 0.031514 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000155 | 1A | 2020-10-30 | 2020-09-26 | 0000320193-20-000096 | false | |||||
AAPL | 2,020 | China | 3 | AAPL_10-K_2020_1A_0009 | 26 | Information Technology | 0.03125 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000098 | 1A | 2020-10-30 | 2020-09-26 | 0000320193-20-000096 | false | |||||
AAPL | 2,021 | China | 1 | AAPL_10-K_2021_1A_0003 | 27 | Information Technology | 0.032787 | false | tensions between the U.S. and China have led to a series of tariffs being imposed by the U.S. on imports from China mainland, as well as other business restrictions. Tariffs increase the cost of the Company's products | -1 | These increased costs adversely impact the gross margin that the Company earns on its products. | 1 | tensions between the U.S. and China have led to a series of tariffs being imposed by the U.S. on imports from China mainland | 2 | could make the Company's products less competitive and reduce consumer demand | 2 | a series of tariffs being imposed by the U.S. on imports from China mainland | 2 | claude-haiku-5-5 | 0.000141 | 1A | 2021-10-29 | 2021-09-25 | 0000320193-21-000105 | true |
AAPL | 2,021 | China | 2 | AAPL_10-K_2021_1A_0016 | 28 | Information Technology | 0.031754 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.00015 | 1A | 2021-10-29 | 2021-09-25 | 0000320193-21-000105 | false | |||||
AAPL | 2,021 | China | 3 | AAPL_10-K_2021_1A_0020 | 29 | Information Technology | 0.030798 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000144 | 1A | 2021-10-29 | 2021-09-25 | 0000320193-21-000105 | false | |||||
AAPL | 2,022 | China | 1 | AAPL_10-K_2022_1A_0003 | 30 | Information Technology | 0.032787 | false | tensions between the U.S. and China have led to a series of tariffs being imposed by the U.S. on imports from China mainland, as well as other business restrictions | -1 | can materially adversely affect the Company's business, particularly if these measures occur in regions where the Company derives a significant portion of its revenues | 2 | tensions between the U.S. and China have led to a series of tariffs being imposed by the U.S. on imports from China mainland | 2 | If disputes and conflicts further escalate in the future, actions by governments in response could be significantly more severe and restrictive and could materially adversely affect the Company's business | 2 | tariffs being imposed by the U.S. on imports from China mainland, as well as other business restrictions | 2 | claude-haiku-5-5 | 0.00016 | 1A | 2022-10-28 | 2022-09-24 | 0000320193-22-000108 | true |
AAPL | 2,022 | China | 2 | AAPL_10-K_2022_1A_0016 | 31 | Information Technology | 0.031754 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000153 | 1A | 2022-10-28 | 2022-09-24 | 0000320193-22-000108 | false | |||||
AAPL | 2,022 | China | 3 | AAPL_10-K_2022_1A_0002 | 32 | Information Technology | 0.03101 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000145 | 1A | 2022-10-28 | 2022-09-24 | 0000320193-22-000108 | false | |||||
AAPL | 2,023 | China | 1 | AAPL_10-K_2023_1A_0002 | 33 | Information Technology | 0.032787 | false | Restrictions on international trade, such as tariffs and other controls on imports or exports of goods, technology or data, can materially adversely affect the Company's operations and supply chain | -1 | can materially adversely affect the Company's operations and supply chain | 1 | tensions between governments, including the U.S. and China, have in the past led to tariffs and other restrictions being imposed on the Company's business | 2 | If disputes and conflicts further escalate in the future, actions by governments in response could be significantly more severe and restrictive and could materially adversely affect the Company's business | 2 | outsourcing partners located primarily in China mainland, India, Japan, South Korea, Taiwan and Vietnam | 2 | claude-haiku-5-5 | 0.000153 | 1A | 2023-11-03 | 2023-09-30 | 0000320193-23-000106 | true |
AAPL | 2,023 | China | 2 | AAPL_10-K_2023_1A_0015 | 34 | Information Technology | 0.032002 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000158 | 1A | 2023-11-03 | 2023-09-30 | 0000320193-23-000106 | false | |||||
AAPL | 2,023 | China | 3 | AAPL_10-K_2023_1A_0020 | 35 | Information Technology | 0.030798 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000151 | 1A | 2023-11-03 | 2023-09-30 | 0000320193-23-000106 | false | |||||
AAPL | 2,024 | China | 1 | AAPL_10-K_2024_1A_0001 | 36 | Information Technology | 0.032522 | false | Restrictions on international trade... can materially adversely affect the Company's business and supply chain; tensions between governments, including the U.S. and China, have in the past led to tariffs and other restrictions affecting the Company's business | -1 | can materially adversely affect the Company's business and supply chain | 2 | tensions between governments, including the U.S. and China, have in the past led to tariffs and other restrictions affecting the Company's business. If disputes and conflicts further escalate in the future | 1 | If disputes and conflicts further escalate in the future, actions by governments in response could be significantly more severe and restrictive and could materially adversely affect the Company's business | 2 | outsourcing partners located primarily in China mainland, India, Japan, South Korea, Taiwan and Vietnam; tariffs and other controls on imports or exports of goods, technology or data | 2 | claude-haiku-5-5 | 0.000181 | 1A | 2024-11-01 | 2024-09-28 | 0000320193-24-000123 | true |
AAPL | 2,024 | China | 2 | AAPL_10-K_2024_1A_0015 | 37 | Information Technology | 0.032018 | false | the Company's products could be banned, delayed or prohibited from importation, which could materially adversely affect the Company's business | -1 | could materially adversely affect the Company's business, reputation, results of operations and financial condition | 1 | the Company is subject to changing regulations relating to the export and import of its products | 1 | could materially adversely affect; Regulatory changes ... may be announced with little or no advance notice | 2 | the export and import of its products; the Company's products could be banned, delayed or prohibited from importation | 1 | claude-haiku-5-5 | 0.000135 | 1A | 2024-11-01 | 2024-09-28 | 0000320193-24-000123 | false |
AAPL | 2,024 | China | 3 | AAPL_10-K_2024_1A_0006 | 38 | Information Technology | 0.031258 | false | manufacturing or logistics in these locations or transit to final destinations can be disrupted ... trade and other international disputes, geopolitical tensions, or conflict | -1 | Passage is boilerplate on supply risks for China-linked Asia manufacturing; no described China-specific effect beyond general disruption risk | 1 | manufacturing or logistics in these locations ... can be disrupted; Such disruptions could occur in the future | 0 | can be disrupted for a variety of reasons; involve significant risks and uncertainties | 2 | outsourcing partners primarily located in Asia; trade and other international disputes, geopolitical tensions | 1 | claude-haiku-5-5 | 0.00014 | 1A | 2024-11-01 | 2024-09-28 | 0000320193-24-000123 | false |
AAPL | 2,025 | China | 1 | AAPL_10-K_2025_1A_0002 | 39 | Information Technology | 0.032787 | false | can materially adversely affect the Company's business and supply chain | -1 | can materially adversely affect the Company's business and supply chain | 2 | Beginning in the second quarter of 2025, new tariffs were announced on imports to the U.S. ... including additional tariffs on imports from China | 2 | The ultimate impact remains uncertain | 3 | Section 232 of the Trade Expansion Act of 1962 ... imports of semiconductors, semiconductor manufacturing equipment | 2 | claude-haiku-5-5 | 0.000138 | 1A | 2025-10-31 | 2025-09-27 | 0000320193-25-000079 | true |
AAPL | 2,025 | China | 2 | AAPL_10-K_2025_7_0003 | 40 | Information Technology | 0.031754 | false | additional tariffs on imports from China ... several countries have imposed, or threatened to impose, reciprocal tariffs ... can have a material adverse impact on the Company's business | -1 | can have a material adverse impact on the Company's business, results of operations and financial condition | 2 | Beginning in the second quarter of 2025, new U.S. Tariffs were announced, including additional tariffs on imports from China | 1 | The ultimate impact remains uncertain and will depend on several factors | 3 | additional tariffs on imports from China, India, Japan, South Korea, Taiwan, Vietnam and the EU ... Section 232 of the Trade Expansion Act of 1962 ... imports of semiconductors | 2 | claude-haiku-5-5 | 0.000131 | 7 | 2025-10-31 | 2025-09-27 | 0000320193-25-000079 | true |
AAPL | 2,025 | China | 3 | AAPL_10-K_2025_1A_0013 | 41 | Information Technology | 0.031258 | false | the Company is subject to changing regulations relating to the export and import of its products. ... products could be banned, delayed or prohibited from importation | -1 | could materially adversely affect the Company's business | 0 | For example, the Company is subject to changing regulations relating to the export and import of its products. | 0 | the Company's products could be banned, delayed or prohibited from importation | 2 | anticorruption; import, export and trade | 1 | claude-haiku-5-5 | 0.000126 | 1A | 2025-10-31 | 2025-09-27 | 0000320193-25-000079 | false |
ABBV | 2,019 | China | 1 | ABBV_10-K_2019_1A_0009 | 42 | Health Care | 0.032266 | false | international trade disruptions or disputes, including in connection with the ongoing trade negotiations between the United States and China | -1 | 1 | ongoing trade negotiations between the United States and China | 1 | Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect on AbbVie's revenues and profitability. | 2 | international trade disruptions or disputes, including in connection with the ongoing trade negotiations between the United States and China | 1 | claude-haiku-5-5 | 0.00013 | 1A | 2020-02-21 | 2019-12-31 | 0001551152-20-000007 | true | |
ABBV | 2,019 | China | 2 | ABBV_10-K_2019_1A_0008 | 43 | Health Care | 0.031319 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000109 | 1A | 2020-02-21 | 2019-12-31 | 0001551152-20-000007 | false | |||||
ABBV | 2,019 | China | 3 | ABBV_10-K_2019_1A_0006 | 44 | Health Care | 0.031025 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000099 | 1A | 2020-02-21 | 2019-12-31 | 0001551152-20-000007 | false | |||||
ABBV | 2,020 | China | 1 | ABBV_10-K_2020_1A_0010 | 45 | Health Care | 0.032787 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000134 | 1A | 2021-02-19 | 2020-12-31 | 0001551152-21-000008 | false | |||||
ABBV | 2,020 | China | 2 | ABBV_10-K_2020_1A_0006 | 46 | Health Care | 0.031746 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000099 | 1A | 2021-02-19 | 2020-12-31 | 0001551152-21-000008 | false | |||||
ABBV | 2,020 | China | 3 | ABBV_10-K_2020_1A_0009 | 47 | Health Care | 0.030331 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000135 | 1A | 2021-02-19 | 2020-12-31 | 0001551152-21-000008 | false | |||||
ABBV | 2,021 | China | 1 | ABBV_10-K_2021_1A_0011 | 48 | Health Care | 0.031545 | false | multiple legal and regulatory requirements that are subject to change and that could restrict AbbVie's ability to manufacture, market and sell its products; Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect | -1 | Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect on AbbVie's revenues and profitability | 0 | could restrict AbbVie's ability; could be adversely affected | 0 | may, individually or in the aggregate, have a material adverse effect | 2 | trade protection measures and import or export licensing requirements; international trade disruptions or disputes; United Kingdom's exit from the European Union | 1 | claude-haiku-5-5 | 0.000144 | 1A | 2022-02-18 | 2021-12-31 | 0001551152-22-000007 | false |
ABBV | 2,021 | China | 2 | ABBV_10-K_2021_1A_0010 | 49 | Health Care | 0.031099 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000125 | 1A | 2022-02-18 | 2021-12-31 | 0001551152-22-000007 | false | |||||
ABBV | 2,021 | China | 3 | ABBV_10-K_2021_1A_0007 | 50 | Health Care | 0.03101 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000131 | 1A | 2022-02-18 | 2021-12-31 | 0001551152-22-000007 | false | |||||
ABBV | 2,022 | China | 1 | ABBV_10-K_2022_1A_0011 | 51 | Health Care | 0.032258 | false | international trade disruptions or disputes; trade protection measures and import or export licensing requirements | -1 | 0 | 0 | 2 | 0 | claude-haiku-5-5 | 0.000097 | 1A | 2023-02-17 | 2022-12-31 | 0001551152-23-000011 | false | ||||
ABBV | 2,022 | China | 2 | ABBV_10-K_2022_7_0003 | 52 | Health Care | 0.031778 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000108 | 7 | 2023-02-17 | 2022-12-31 | 0001551152-23-000011 | false | |||||
ABBV | 2,022 | China | 3 | ABBV_10-K_2022_1A_0007 | 53 | Health Care | 0.030579 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000137 | 1A | 2023-02-17 | 2022-12-31 | 0001551152-23-000011 | false | |||||
ABBV | 2,023 | China | 1 | ABBV_10-K_2023_1A_0011 | 54 | Health Care | 0.032266 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000134 | 1A | 2024-02-20 | 2023-12-31 | 0001551152-24-000011 | false | |||||
ABBV | 2,023 | China | 2 | ABBV_10-K_2023_1A_0010 | 55 | Health Care | 0.031099 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000136 | 1A | 2024-02-20 | 2023-12-31 | 0001551152-24-000011 | false | |||||
ABBV | 2,023 | China | 3 | ABBV_10-K_2023_1A_0008 | 56 | Health Care | 0.030536 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000129 | 1A | 2024-02-20 | 2023-12-31 | 0001551152-24-000011 | false | |||||
ABBV | 2,024 | China | 1 | ABBV_10-K_2024_1A_0012 | 57 | Health Care | 0.031545 | false | The international nature of AbbVie's business subjects it to additional business risks that may cause its revenue and profitability to decline | -1 | 0 | Net revenues outside of the United States made up approximately 24% of AbbVie's total net revenues in 2024 | 0 | may cause its revenue and profitability to decline | 2 | Passage mentions China only generically within a list of international risks; no China-specific details such as named regulations, counterparties, or amounts | 0 | claude-haiku-5-5 | 0.000126 | 1A | 2025-02-14 | 2024-12-31 | 0001551152-25-000020 | false | |
ABBV | 2,024 | China | 2 | ABBV_10-K_2024_1A_0011 | 58 | Health Care | 0.030679 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000137 | 1A | 2025-02-14 | 2024-12-31 | 0001551152-25-000020 | false | |||||
ABBV | 2,024 | China | 3 | ABBV_10-K_2024_1A_0009 | 59 | Health Care | 0.030536 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000129 | 1A | 2025-02-14 | 2024-12-31 | 0001551152-25-000020 | false | |||||
ABBV | 2,025 | China | 1 | ABBV_10-K_2025_1A_0012 | 60 | Health Care | 0.032522 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000155 | 1A | 2026-02-20 | 2025-12-31 | 0001551152-26-000008 | false | |||||
ABBV | 2,025 | China | 2 | ABBV_10-K_2025_1A_0008 | 61 | Health Care | 0.031099 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000142 | 1A | 2026-02-20 | 2025-12-31 | 0001551152-26-000008 | false | |||||
ABBV | 2,025 | China | 3 | ABBV_10-K_2025_1A_0011 | 62 | Health Care | 0.030835 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000126 | 1A | 2026-02-20 | 2025-12-31 | 0001551152-26-000008 | false | |||||
ABNB | 2,020 | China | 1 | ABNB_10-K_2020_1A_0034 | 63 | Consumer Discretionary | 0.032787 | false | could materially adversely affect our brand, reputation, business, results of operations, and financial condition | -1 | could materially adversely affect our brand, reputation, business | 2 | Failure to comply with such requests or other requirements as interpreted by government agencies may lead to impairment or disruption to our business | 0 | it is uncertain what obligations will apply to us in the future; there are substantial uncertainties as to its ultimate interpretation and whether it applies to us | 2 | China's first cybersecurity law ("CSL") took effect in June 2017; "critical information infrastructure"; VIE and wholly-foreign owned entity; data localization requirements | 2 | claude-haiku-5-5 | 0.000157 | 1A | 2021-02-26 | 2020-12-31 | 0001559720-21-000010 | true |
ABNB | 2,020 | China | 2 | ABNB_10-K_2020_1A_0033 | 64 | Consumer Discretionary | 0.032002 | false | we have invested heavily to expand our operations in China, which is an intensely competitive market ... we may not achieve profitability in that market | -1 | we expect to continue to incur significant expenses to operate our business in China | 2 | we have invested heavily to expand our operations in China | 2 | we may not achieve profitability in that market ... may particularly impact our operations in China | 2 | China's policy towards foreign direct investment; sentiment of the workforce in China; modifications to the way our website, mobile apps ... function in China | 2 | claude-haiku-5-5 | 0.000132 | 1A | 2021-02-26 | 2020-12-31 | 0001559720-21-000010 | true |
ABNB | 2,020 | China | 3 | ABNB_10-K_2020_1A_0073 | 65 | Consumer Discretionary | 0.031754 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000134 | 1A | 2021-02-26 | 2020-12-31 | 0001559720-21-000010 | false | |||||
ABNB | 2,021 | China | 1 | ABNB_10-K_2021_1A_0035 | 66 | Consumer Discretionary | 0.032787 | false | could materially adversely affect our brand, reputation, business, results of operations, and financial condition; we may never achieve profitability or sizable supply penetration in that market | -1 | we will continue to incur significant expenses to operate our business in China | 2 | we will continue to incur significant expenses to operate our business in China; Chinese government has adopted laws, regulations and implementation measures | 1 | At this point, it is uncertain what obligations will apply to us in the future, and we cannot predict what impact these new laws and regulations | 3 | laws, regulations and implementation measures that govern the dissemination of content over the Internet and data processing in China; licenses to operate in China, the blocking of our platform | 2 | claude-haiku-5-5 | 0.00015 | 1A | 2022-02-25 | 2021-12-31 | 0001559720-22-000006 | true |
ABNB | 2,021 | China | 2 | ABNB_10-K_2021_1A_0074 | 67 | Consumer Discretionary | 0.031498 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.00015 | 1A | 2022-02-25 | 2021-12-31 | 0001559720-22-000006 | false | |||||
ABNB | 2,021 | China | 3 | ABNB_10-K_2021_1A_0036 | 68 | Consumer Discretionary | 0.031281 | false | we could be subject to penalties, be forced to cease our operations in China, or be subject to restrictions | -1 | we could be subject to penalties, be forced to cease our operations in China | 2 | if the Chinese government deems that the contractual arrangements ... do not comply | 0 | we could be subject to penalties, be forced to cease our operations in China, or be subject to restrictions in the future | 2 | contractual arrangements with the equity holders of our VIE ... Chinese tax authorities ... related party transaction pricing | 2 | claude-haiku-5-5 | 0.000141 | 1A | 2022-02-25 | 2021-12-31 | 0001559720-22-000006 | true |
ABNB | 2,022 | China | 1 | ABNB_10-K_2022_1A_0021 | 69 | Consumer Discretionary | 0.032787 | false | may particularly impact our operations in China; may lead to impairment or disruption to our business and operations; could materially adversely affect our brand, reputation, business, results of operations | -1 | we may never achieve profitability in that market; could adversely affect our outbound business in China | 2 | we will continue to incur significant expenses to operate our outbound business in China; Failure to comply ... may lead to; could be subject to penalties | 0 | At this point, it is uncertain what obligations will apply to us in the future, and we cannot predict what impact these new laws and regulations | 3 | variable interest entity (VIE) and a wholly-foreign owned entity; laws, regulations, and implementation measures that govern the dissemination of content over the Internet and data processing in China; Executive Orders or trade blacklists | 2 | claude-haiku-5-5 | 0.000164 | 1A | 2023-02-17 | 2022-12-31 | 0001559720-23-000003 | true |
ABNB | 2,022 | China | 2 | ABNB_10-K_2022_1A_0074 | 70 | Consumer Discretionary | 0.032258 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000147 | 1A | 2023-02-17 | 2022-12-31 | 0001559720-23-000003 | false | |||||
ABNB | 2,022 | China | 3 | ABNB_10-K_2022_1A_0073 | 71 | Consumer Discretionary | 0.030077 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000122 | 1A | 2023-02-17 | 2022-12-31 | 0001559720-23-000003 | false | |||||
ABNB | 2,023 | China | 1 | ABNB_10-K_2023_1A_0019 | 72 | Consumer Discretionary | 0.032787 | false | we could be subject to penalties, be forced to cease our operations in China, or be subject to restrictions in the future | -1 | we cannot predict what impact these new laws and regulations or the increased costs of compliance, if any, will have on our operations in China | 1 | The Chinese government has adopted laws, regulations, and implementation measures that govern the dissemination of content over the Internet and data processing in China | 1 | it is uncertain what obligations will apply to us in the future, and we cannot predict what impact | 3 | contractual arrangements with the equity holders of our VIE; trade blacklists to ban or limit the use of services provided by Chinese third parties; variable interest entity | 2 | claude-haiku-5-5 | 0.000133 | 1A | 2024-02-16 | 2023-12-31 | 0001559720-24-000006 | true |
ABNB | 2,023 | China | 2 | ABNB_10-K_2023_1A_0018 | 73 | Consumer Discretionary | 0.032258 | false | we will continue to incur significant expenses to operate our outbound business in China, and we may never achieve profitability in that market | -1 | could materially adversely affect our brand, reputation, business, results of operations, and financial condition | 1 | we need to ensure that our business practices in China are compliant with local laws | 1 | could adversely affect our outbound business in China | 2 | We are subject to various requirements and requests from government agencies to share information on users who use services in China through our platform | 2 | claude-haiku-5-5 | 0.000137 | 1A | 2024-02-16 | 2023-12-31 | 0001559720-24-000006 | true |
ABNB | 2,023 | China | 3 | ABNB_10-K_2023_1A_0069 | 74 | Consumer Discretionary | 0.031025 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000111 | 1A | 2024-02-16 | 2023-12-31 | 0001559720-24-000006 | false | |||||
ABNB | 2,024 | China | 1 | ABNB_10-K_2024_1A_0028 | 75 | Consumer Discretionary | 0.032522 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000173 | 1A | 2025-02-13 | 2024-12-31 | 0001559720-25-000010 | false | |||||
ABNB | 2,024 | China | 2 | ABNB_10-K_2024_1A_0024 | 76 | Consumer Discretionary | 0.031258 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000141 | 1A | 2025-02-13 | 2024-12-31 | 0001559720-25-000010 | false | |||||
ABNB | 2,024 | China | 3 | ABNB_10-K_2024_1A_0037 | 77 | Consumer Discretionary | 0.030331 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000147 | 1A | 2025-02-13 | 2024-12-31 | 0001559720-25-000010 | false | |||||
ABNB | 2,025 | China | 1 | ABNB_10-K_2025_1A_0039 | 78 | Consumer Discretionary | 0.032522 | false | With regard to China, the regulatory requirements on AI and ML Technologies, export controls and other relevant regulations are still evolving and have ongoing complexity and uncertainty. | -1 | may impact our ability, or require additional resources (which may be substantial), to develop and/or maintain related product features | 1 | are still evolving and have ongoing complexity and uncertainty | 1 | The positions and interpretation of these regulations by the authorities may not align with our interpretation | 2 | With regard to China, the regulatory requirements on AI and ML Technologies, export controls and other relevant regulations | 1 | claude-haiku-5-5 | 0.000134 | 1A | 2026-02-12 | 2025-12-31 | 0001559720-26-000004 | true |
ABNB | 2,025 | China | 2 | ABNB_10-K_2025_1A_0034 | 79 | Consumer Discretionary | 0.032522 | false | Our China-related content: DOJ rule aimed at preventing access by "countries of concern" (including China)... could materially impact our business operations or hinder our ability to grow | -1 | Compliance with the rule may require us to stop or restrict certain data transfers... could materially impact our business operations or hinder our ability to grow our business | 2 | in 2025 the DOJ issued a new rule... has yet to be enforced | 1 | there is a risk that our interpretation of its applicability, scope, and requirements is incorrect, incomplete, or misapplied | 2 | DOJ issued a new rule, to implement Executive Order 14117 aimed at preventing access to "bulk U.S. sensitive personal data" ... by "countries of concern" (including China, Russia, Iran, North Korea, Cuba, and Venezuela) | 2 | claude-haiku-5-5 | 0.000167 | 1A | 2026-02-12 | 2025-12-31 | 0001559720-26-000004 | true |
ABNB | 2,025 | China | 3 | ABNB_10-K_2025_7_0004 | 80 | Consumer Discretionary | 0.030798 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000058 | 7 | 2026-02-12 | 2025-12-31 | 0001559720-26-000004 | false | |||||
ABT | 2,019 | China | 1 | ABT_10-K_2019_1A_0007 | 81 | Health Care | 0.032266 | false | subjects it to additional business risks that may cause its revenue and profitability to decline | -1 | Sales outside of the United States in 2019 made up approximately 64 percent of Abbott's net sales | 1 | Additional risks associated with Abbott's international operations include | 0 | may, individually or in the aggregate, have a material adverse effect | 2 | restrictions on local currency conversion and/or cash extraction; price controls ... the Foreign Corrupt Practices Act and the U.K. Bribery Act | 1 | claude-haiku-5-5 | 0.000134 | 1A | 2020-02-21 | 2019-12-31 | 0001104659-20-023904 | false |
ABT | 2,019 | China | 2 | ABT_10-K_2019_7_0010 | 82 | Health Care | 0.030886 | false | challenging market dynamics in the Greater China infant category; growth in several geographies including China; sales in India and China experienced double-digit growth | 0 | Greater China infant category challenges offset growth; China growth is one of several geographies within emerging markets increasing 7.9 percent; no China-specific size stated | 1 | sales in these key emerging markets increased 7.9 percent in 2019 due to growth in several geographies including China | 2 | 0 | Greater China infant category; China named as key emerging market; Similac and PediaSure in Asia and Latin America | 2 | claude-haiku-5-5 | 0.000146 | 7 | 2020-02-21 | 2019-12-31 | 0001104659-20-023904 | true | |
ABT | 2,019 | China | 3 | ABT_10-K_2019_1A_0001 | 83 | Health Care | 0.030835 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000101 | 1A | 2020-02-21 | 2019-12-31 | 0001104659-20-023904 | false | |||||
ABT | 2,020 | China | 1 | ABT_10-K_2020_1A_0008 | 84 | Health Care | 0.032522 | false | restrictions on local currency conversion and/or cash extraces; trade protection measures, including tariffs; Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect on Abbott's revenues and profitability | -1 | Sales outside of the United States in 2020 made up approximately 62 percent of Abbott's net sales | 1 | Additional risks associated with Abbott's international operations include | 0 | Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect | 2 | changes to international trade agreements; restrictions on local currency conversion; Foreign Corrupt Practices Act and the U.K. Bribery Act | 1 | claude-haiku-5-5 | 0.000144 | 1A | 2021-02-19 | 2020-12-31 | 0001104659-21-025751 | false |
ABT | 2,020 | China | 2 | ABT_10-K_2020_1A_0007 | 85 | Health Care | 0.03101 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000137 | 1A | 2021-02-19 | 2020-12-31 | 0001104659-21-025751 | false | |||||
ABT | 2,020 | China | 3 | ABT_10-K_2020_7_0011 | 86 | Health Care | 0.029907 | false | challenging market dynamics in the infant category in Greater China; growth in several geographies including China | -1 | International Pediatric Nutritional sales decreased 4.1 percent; key emerging markets including China increased 2.6 percent | 1 | sales in these key emerging markets increased 2.6 percent in 2020 due to higher sales in several geographies including China; challenging market dynamics in the infant category in Greater China | 2 | 0 | infant category in Greater China; Similac and PediaSure in various countries in Asia | 2 | claude-haiku-5-5 | 0.000131 | 7 | 2021-02-19 | 2020-12-31 | 0001104659-21-025751 | true | |
ABT | 2,021 | China | 1 | ABT_10-K_2021_1A_0008 | 87 | Health Care | 0.032787 | false | Deterioration in the economic condition and credit quality of certain countries may negatively affect Abbott's results | -1 | 0 | 0 | may negatively affect Abbott's results of operations | 2 | 0 | claude-haiku-5-5 | 0.000105 | 1A | 2022-02-18 | 2021-12-31 | 0001104659-22-025141 | false | |||
ABT | 2,021 | China | 2 | ABT_10-K_2021_1A_0003 | 88 | Health Care | 0.029828 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000102 | 1A | 2022-02-18 | 2021-12-31 | 0001104659-22-025141 | false | |||||
ABT | 2,021 | China | 3 | ABT_10-K_2021_1A_0006 | 89 | Health Care | 0.029514 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000098 | 1A | 2022-02-18 | 2021-12-31 | 0001104659-22-025141 | false | |||||
ABT | 2,022 | China | 1 | ABT_10-K_2022_1A_0009 | 90 | Health Care | 0.032522 | false | Deterioration in the economic condition and credit quality of certain countries may negatively affect Abbott's results | -1 | Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect on Abbott's revenues and profitability. | 1 | may negatively affect Abbott's results of operations | 0 | may negatively affect; could increase Abbott's collection risk | 2 | Sales outside of the United States in 2022 made up approximately 58 percent of Abbott's net sales; Foreign Corrupt Practices Act and the U.K. Bribery Act | 1 | claude-haiku-5-5 | 0.000135 | 1A | 2023-02-17 | 2022-12-31 | 0001628280-23-004026 | false |
ABT | 2,022 | China | 2 | ABT_10-K_2022_1A_0010 | 91 | Health Care | 0.029727 | false | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000098 | 1A | 2023-02-17 | 2022-12-31 | 0001628280-23-004026 | false | |||||
ABT | 2,022 | China | 3 | ABT_10-K_2022_1A_0004 | 92 | Health Care | 0.02967 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000122 | 1A | 2023-02-17 | 2022-12-31 | 0001628280-23-004026 | false | |||||
ABT | 2,023 | China | 1 | ABT_10-K_2023_1A_0009 | 93 | Health Care | 0.032258 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000154 | 1A | 2024-02-16 | 2023-12-31 | 0001628280-24-005348 | false | |||||
ABT | 2,023 | China | 2 | ABT_10-K_2023_1A_0008 | 94 | Health Care | 0.031258 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000107 | 1A | 2024-02-16 | 2023-12-31 | 0001628280-24-005348 | false | |||||
ABT | 2,023 | China | 3 | ABT_10-K_2023_1A_0010 | 95 | Health Care | 0.030092 | false | potential penalties or other adverse consequences for violations of anti-corruption, anti-bribery, and other similar laws and regulations, including the Foreign Corrupt Practices Act | -1 | Events contemplated by these risks may, individually or in the aggregate, have a material adverse effect on Abbott's revenues and profitability. | 0 | 0 | Events contemplated by these risks may | 2 | Foreign Corrupt Practices Act and the U.K. Bribery Act | 2 | claude-haiku-5-5 | 0.000138 | 1A | 2024-02-16 | 2023-12-31 | 0001628280-24-005348 | false | |
ABT | 2,024 | China | 1 | ABT_10-K_2024_1A_0008 | 96 | Health Care | 0.032787 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000156 | 1A | 2025-02-21 | 2024-12-31 | 0001628280-25-007110 | false | |||||
ABT | 2,024 | China | 2 | ABT_10-K_2024_1A_0007 | 97 | Health Care | 0.032002 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000144 | 1A | 2025-02-21 | 2024-12-31 | 0001628280-25-007110 | false | |||||
ABT | 2,024 | China | 3 | ABT_10-K_2024_1A_0009 | 98 | Health Care | 0.030622 | true | 0 | 0 | 0 | 0 | 0 | claude-haiku-5-5 | 0.000087 | 1A | 2025-02-21 | 2024-12-31 | 0001628280-25-007110 | false | |||||
ABT | 2,025 | China | 1 | ABT_10-K_2025_1A_0007 | 99 | Health Care | 0.032787 | false | could negatively affect Abbott's business; could have a negative impact on macroeconomic conditions | -1 | 0 | The U.S. government has imposed tariffs on imports into the U.S., and it may impose additional tariffs in the future | 1 | it is difficult to predict the future implications and consequences of the conflict | 2 | Some countries may retaliate with trade protection measures, including reciprocal tariffs | 1 | claude-haiku-5-5 | 0.000122 | 1A | 2026-02-20 | 2025-12-31 | 0001628280-26-010185 | false |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.